782 related articles for article (PubMed ID: 19114099)
21. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
Shin SC; Choi JS
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
[TBL] [Abstract][Full Text] [Related]
22. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
[TBL] [Abstract][Full Text] [Related]
23. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
[TBL] [Abstract][Full Text] [Related]
24. Novel biomaterial for transdermal application: in vitro and in vivo characterization.
Mundada AS; Avari JG
Drug Deliv; 2011 Aug; 18(6):424-31. PubMed ID: 21554152
[TBL] [Abstract][Full Text] [Related]
25. In vivo evaluation of limonene-based transdermal therapeutic system of nicorandil in healthy human volunteers.
Krishnaiah YS; Chandrasekhar DV; Rama B; Jayaram B; Satyanarayana V; Al-Saidan SM
Skin Pharmacol Physiol; 2005; 18(6):263-72. PubMed ID: 16113596
[TBL] [Abstract][Full Text] [Related]
26. Ketorolac tromethamine transdermal gel: development, in vitro and in vivo evaluation.
Dubey R; Bommagani M; Venkateswarlu V; Mullangi R; Karnati HR; Thammera RK; Menon VC
J Pain Palliat Care Pharmacother; 2009; 23(1):26-34. PubMed ID: 19296352
[TBL] [Abstract][Full Text] [Related]
27. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
[TBL] [Abstract][Full Text] [Related]
28. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
Eur J Pharm Sci; 2014 Feb; 52():86-94. PubMed ID: 24215737
[TBL] [Abstract][Full Text] [Related]
29. Development of a Prolonged-Release Pramipexole Transdermal Patch: In Vitro and In Vivo Evaluation.
Pu T; Li X; Sun Y; Ding X; Pan Y; Wang Q
AAPS PharmSciTech; 2017 Apr; 18(3):738-748. PubMed ID: 27245330
[TBL] [Abstract][Full Text] [Related]
30. Formulation and Pharmacokinetic Evaluation of a Drug-in-Adhesive Patch for Transdermal Delivery of Koumine.
Su Y; Lu W; Fu X; Xu Y; Ye L; Yang J; Huang H; Yu C
AAPS PharmSciTech; 2020 Oct; 21(8):297. PubMed ID: 33099696
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate.
Patel SR; Zhong H; Sharma A; Kalia YN
Eur J Pharm Biopharm; 2007 May; 66(2):296-301. PubMed ID: 17182233
[TBL] [Abstract][Full Text] [Related]
32. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity.
Zhao L; Fang L; Xu Y; Zhao Y; He Z
Int J Pharm; 2008 Mar; 352(1-2):92-103. PubMed ID: 18053661
[TBL] [Abstract][Full Text] [Related]
33. Transdermal delivery of tolterodine by O-acylmenthol: In vitro/in vivo correlation.
Zhao L; Li Y; Fang L; He Z; Liu X; Wang L; Xu Y; Ren C
Int J Pharm; 2009 Jun; 374(1-2):73-81. PubMed ID: 19446762
[TBL] [Abstract][Full Text] [Related]
34. Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits.
Rao PR; Reddy MN; Ramakrishna S; Diwan PV
Eur J Pharm Biopharm; 2003 Jul; 56(1):81-5. PubMed ID: 12837485
[TBL] [Abstract][Full Text] [Related]
35. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
Mutalik S; Udupa N
J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
[TBL] [Abstract][Full Text] [Related]
36. Biodegradable derivatives of tranexamic acid as transdermal permeation enhancers.
Vávrová K; Hrabálek A; Dolezal P; Holas T; Klimentová J
J Control Release; 2005 May; 104(1):41-9. PubMed ID: 15866333
[TBL] [Abstract][Full Text] [Related]
37. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
Panchagnula R; Bokalial R; Sharma P; Khandavilli S
Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
[TBL] [Abstract][Full Text] [Related]
38. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
Gao Y; Liang J; Liu J; Xiao Y
Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
[TBL] [Abstract][Full Text] [Related]
39. Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate.
Balaguer-Fernández C; Padula C; Femenía-Font A; Merino V; Santi P; López-Castellano A
Drug Deliv; 2010 Feb; 17(2):83-91. PubMed ID: 20067437
[TBL] [Abstract][Full Text] [Related]
40. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
